Codexis at TIDES – Stereochemistry in RNA Manufacturing: Signal or Noise?

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:

• Fred Fleitz, SVP, CMC and Development Chemistry, Arrowhead Pharmaceuticals
• Jason Costigan, Head of CMC, Corsera Health
• Alison Moore, CEO and President, Codexis Inc.
• Muthu Kandasamy, VP of Medicinal Chemistry, Wave Life Sciences 

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests live from TIDES 2026. The event was hosted by Codexis and Molecule to Market,

Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!